estrone has been researched along with rhein in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, LZ; Sun, WJ; Wang, Y; Wu, J; Zhang, YL; Zhu, YQ | 1 |
Cui, Y; Li, LZ; Qi, L; Sun, WJ; Wang, Y; Zhang, YL; Zhu, YQ | 1 |
2 other study(ies) available for estrone and rhein
Article | Year |
---|---|
LC, a novel estrone-rhein hybrid compound, concurrently stimulates osteoprotegerin and inhibits receptor activator of NF-κB ligand (RANKL) and interleukin-6 production by human osteoblastic cells.
Topics: Animals; Anthraquinones; Cell Line; Cell Proliferation; Endoplasmic Reticulum; Enzyme Activation; Estrogen Receptor alpha; Estrogen Receptor beta; Estrone; Female; Gene Knockdown Techniques; Humans; Interleukin-6; Intracellular Signaling Peptides and Proteins; Osteoblasts; Osteoprotegerin; Promoter Regions, Genetic; RANK Ligand; Rats; Response Elements; RNA Interference; Signal Transduction | 2011 |
LC, a novel estrone-rhein hybrid compound, promotes proliferation and differentiation and protects against cell death in human osteoblastic MG-63 cells.
Topics: Alkaline Phosphatase; Anthraquinones; Apoptosis; Apoptosis Regulatory Proteins; Cell Cycle; Cell Differentiation; Cell Line; Cell Proliferation; Cell Survival; Cisplatin; Collagen; Enzyme Assays; Estrogens; Estrone; Gene Expression; Humans; Nuclear Receptor Coactivator 3; Osteoblasts; Receptors, Estrogen; Signal Transduction | 2011 |